[go: up one dir, main page]

TN2019000197A1 - Liquid filled hard capsule comprising effective and flexible single dose of vitamin D - Google Patents

Liquid filled hard capsule comprising effective and flexible single dose of vitamin D

Info

Publication number
TN2019000197A1
TN2019000197A1 TNP/2019/000197A TN2019000197A TN2019000197A1 TN 2019000197 A1 TN2019000197 A1 TN 2019000197A1 TN 2019000197 A TN2019000197 A TN 2019000197A TN 2019000197 A1 TN2019000197 A1 TN 2019000197A1
Authority
TN
Tunisia
Prior art keywords
effective
vitamin
liquid filled
single dose
hard capsule
Prior art date
Application number
TNP/2019/000197A
Other languages
French (fr)
Inventor
Mahmoud ALSWISI
Mohamed Amine Boujbel
Lassaad Boujbel
Original Assignee
Les Laboratoires Medis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Medis filed Critical Les Laboratoires Medis
Priority to TNP/2019/000197A priority Critical patent/TN2019000197A1/en
Publication of TN2019000197A1 publication Critical patent/TN2019000197A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to an effective and flexible dose vitarnin D-containing liquid filled hard capsules.The present invention relates to an effective and flexible dose vitarnin D-containing liquid filled hard capsules.

TNP/2019/000197A 2019-06-27 2019-06-27 Liquid filled hard capsule comprising effective and flexible single dose of vitamin D TN2019000197A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TNP/2019/000197A TN2019000197A1 (en) 2019-06-27 2019-06-27 Liquid filled hard capsule comprising effective and flexible single dose of vitamin D

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TNP/2019/000197A TN2019000197A1 (en) 2019-06-27 2019-06-27 Liquid filled hard capsule comprising effective and flexible single dose of vitamin D

Publications (1)

Publication Number Publication Date
TN2019000197A1 true TN2019000197A1 (en) 2020-10-05

Family

ID=78467354

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP/2019/000197A TN2019000197A1 (en) 2019-06-27 2019-06-27 Liquid filled hard capsule comprising effective and flexible single dose of vitamin D

Country Status (1)

Country Link
TN (1) TN2019000197A1 (en)

Similar Documents

Publication Publication Date Title
CL2021001292A1 (en) Combination therapy including a krasg12c inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
MX392436B (en) CANNABINOID FORMULATIONS.
MX378273B (en) ACTIVE COMPOUNDS TOWARDS BROMODOMAINS.
MX2019009853A (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.
MY192588A (en) Pharmaceutical compounds
CL2015001983A1 (en) Androgen receptor modulator and uses of this.
CO2019007205A2 (en) Therapeutic uses of an insect powder
MX2017000627A (en) METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH).
MX2019014042A (en) Pyrazole magl inhibitors.
GB2587092B (en) Vibrating capsule for enhancing absorption of ingested medicaments
MX2023001963A (en) Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent.
PH12022551468A1 (en) Compounds active towards nuclear receptors
MX2018005358A (en) Optimised high-dose mesalazine-containing tablet.
HUE066917T2 (en) Unit dose capsule
MX2019004973A (en) ROR GAMMA MODULATORS.
MX2021008941A (en) Gpr35 modulators.
MX2022007265A (en) Compounds active towards nuclear receptors.
EA202191378A1 (en) ACTIVE ESTER DERIVATIVES OF TESTOSTERONE, THEIR COMPOSITIONS AND APPLICATIONS
JOP20200126A1 (en) Methods of using and compositions containing dulaglutide
TN2019000197A1 (en) Liquid filled hard capsule comprising effective and flexible single dose of vitamin D
EA202090082A1 (en) COMBINATION OF MCL-1 INHIBITOR AND STANDARD MEDICINAL PRODUCT FOR TREATMENT OF HEMATOLOGICAL MALIGNANT NORMOUS FORMATIONS, ITS APPLICATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
CL2015000052A1 (en) Pharmaceutical composition with improved fluidity, comprising 2-amino-2- [2- (4-octylphenyl) ethyl] propane-1,3-diol, lactulose, peg-6000 and pvp; tablet or capsule that comprises it and method for its production.
EP3965739C0 (en) TABLET DOSAGE FORMULATIONS OF OLEYLPHOSPHOCHOLINE
MX2020004731A (en) Ezh2 inhibitor combination therapies.
AR113874A1 (en) EZH2 INHIBITOR COMBINATION THERAPIES